Financial penalties imposed on large pharmaceutical firms for illegal activities

(University of North Carolina at Charlotte) The UNC Charlotte study examined financial penalties imposed by government agencies using a sample of 26 large pharmaceutical firms over 13 years. Results indicated that 22 firms (85%) were penalized for illegal activities with most firms engaging in illegal activities for four or more years. Total penalties imposed during this period were $33 billion. The most common penalties were pricing violations, off-label marketing, and kickbacks. Four firms had...